1. Home
  2. TECH vs HLN Comparison

TECH vs HLN Comparison

Compare TECH & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$59.83

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.01

Market Cap

44.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
HLN
Founded
1976
2022
Country
United States
United Kingdom
Employees
N/A
24622
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
44.5B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
TECH
HLN
Price
$59.83
$10.01
Analyst Decision
Strong Buy
Hold
Analyst Count
14
1
Target Price
$71.23
N/A
AVG Volume (30 Days)
1.6M
9.4M
Earning Date
02-04-2026
07-31-2025
Dividend Yield
0.54%
1.81%
EPS Growth
N/A
41.64
EPS
0.49
0.23
Revenue
$1,216,732,000.00
$15,096,588,575.00
Revenue This Year
$2.33
$1.51
Revenue Next Year
$7.05
$4.67
P/E Ratio
$122.55
$21.33
Revenue Growth
3.85
N/A
52 Week Low
$46.01
$8.71
52 Week High
$79.28
$11.42

Technical Indicators

Market Signals
Indicator
TECH
HLN
Relative Strength Index (RSI) 50.87 58.70
Support Level $58.54 $10.05
Resistance Level $59.64 $10.15
Average True Range (ATR) 1.46 0.11
MACD 0.11 0.02
Stochastic Oscillator 80.40 76.15

Price Performance

Historical Comparison
TECH
HLN

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: